SHENZHEN HEPALINK PHARMACEUTICAL
(HKEX: 9989)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.
5.350 -
-0.030
(-0.56%)
Range
5.260 - 5.370
(2.09%)
Open
5.370
Previous Close
5.380
Bid Price
5.320
Bid Volume
('000)
204
Ask Price
5.350
Ask Volume
('000)
6.5
Volume
('000)
1,068.5
Value
5,664,755
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
